Publication | Closed Access
Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma
292
Citations
12
References
2009
Year
Pazopanib demonstrated durable activity in patients with advanced RCC and was generally well tolerated in this population. These findings support the further development of pazopanib in advanced RCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1